Phase 4 Rejection Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
Allograft Dysfunction in Heart Transplant
Heart Transplant Failure and Rejection
Paul Kim376 enrolled1 locationNCT03102125
Recruiting
Phase 4
Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure
Graft RejectionGraft FailureRenal Failure Chronic+2 more
Hospital Universitari Vall d'Hebron Research Institute202 enrolled1 locationNCT06676696
Terminated
Phase 4
A Randomised Controlled trial of intravenous immunoglobulin (IVIg) compared with pulse methyl-prednisolone for the treatment of chronic active antibody mediated rejection
chronic active antibody mediated rejection of the renal allograft
Dr William Mulley50 enrolled7 locationsACTRN12612000252819
Active
Phase 4
Ciclosporine Azathioprine versus Tacrolimus mycophenolate mofetil in renal transplantation
Immunosuppressive treatment in renal transplantationAcute rejection and transplant survival in renal transplantation
Assistance publique des Hopitaux de Marseille300 enrolled1 locationACTRN12610000697088